MapMyGenome launches affordable pharmacogenomics solution MedicaMap

Dec 06, 2022



Hyderabad, December 06, 2022:

Hyderabad-based MapMyGenome has launched its pharmacogenomics solution MedicaMap.

MedicaMap is MapMyGenome‘s cutting-edge pharmacogenomic solution that analyses an individual‘s response to medicines, based on genetic makeup. This pharmacogenomic solution analyses 165+ US-FDA-approved drugs across 12 different specialties such as psychiatry, oncology, cardiology, diabetology, and many more.

MapMyGenome CEO Anu Acharya said, "MedicaMap is a one of a kind  phamacogenomic product which provides you detailed analysis of your body‘s response to medicine based on your genetic makeup.

It is affordable, non-invasive, once-in-a lifetime. You can do it from your own home. We have introduced it at Rs 6499 for over 165 drugs, which is probably the lowest price."

Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.